Online citations, reference lists, and bibliographies.

Nanomedicine For Respiratory Diseases.

Ulrich Pison, Tobias Welte, Michael Giersig, David A. Groneberg
Published 2006 · Chemistry, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology provides new materials in the nanometer range with many potential applications in clinical medicine and research. Due to their unique size-dependent properties nanomaterial such as nanoparticles offer the possibility to develop both new therapeutic and diagnostic tools. Thus, applied nanotechnology to medical problems--nanomedicine--can offer new concepts that are reviewed. The ability to incorporate drugs into nanosystems displays a new paradigm in pharmacotherapy that could be used for cell-targeted drug delivery. Nontargeted nanosystems such as nanocarriers that are coated with polymers or albumin and solid lipid particles have been used as transporter in vivo. However, nowadays drugs can be coupled to nanocarriers that are specific for cells and/or organs. Thus, drugs that are either trapped within the carriers or deposited in subsurface oil layers could be specifically delivered to organs, tumors and cells. These strategies can be used to concentrate drugs in selected target tissues thus minimizing systemic side effects and toxicity. In addition to these therapeutic options, nanoparticle-based "molecular" imaging displays a field in which this new technology has set the stage for an evolutionary leap in diagnostic imaging. Based on the recent progress in nanobiotechnology there is potential for nanoparticles and -systems to become useful tools as therapeutic and diagnostic tools in the near future.



This paper is referenced by
10.1152/ajplung.00041.2008
Pulmonary applications and toxicity of engineered nanoparticles.
Jeffrey W. Card (2008)
10.1002/9781118644591.CH5
Nanomaterials for Management of Lung Disorders and Drug Delivery
Jyothi U Menon (2013)
10.3390/nano9101406
Optimization of the Production Process and Product Quality of Titanate Nanotube–Drug Composites
Yasmin Ranjous (2019)
10.1002/APP.38870
Effects of the Hydrophobization on Chitosan-Insulin Nanoparticles Obtained by an Alkylation Reaction on Chitosan
E. M. Hernández Robles (2013)
10.4018/978-1-4666-5125-8.CH071
Nanorevolution and Professionalizing University Education: Opportunities and Obstacles
Mahendra K. Rai (2014)
10.14232/phd.10109
Formulation and aerodynamic evaluation of carrier-free dry powder inhalation systems containing meloxicam
C Risch Anita (2019)
Efecto de los componentes de la formulación en las propiedades de las nanopartículas lipídicas sólidas Effect of formulation components on the properties of solid lipid nanoparticles
Lourdes Garzón (2009)
Iranian Journal of Pathology Nanomedicine
Moslem Bahadori (2006)
10.1016/B978-0-323-46152-8.00013-5
Nanocarrier-Assisted Antimicrobial Therapy Against Intracellular Pathogens
Lalit Kumar (2017)
10.1007/978-981-10-0818-4_6
Theragnosis: Nanoparticles as a Tool for Simultaneous Therapy and Diagnosis
Shanka Walia (2016)
Polymeric nanocarriers for the regional and systemic delivery of therapeutics to and through the lungs
Balaji Bharatwaj (2012)
10.1016/j.ijpharm.2010.06.006
Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages.
H Eidi (2010)
10.1016/j.jinorgbio.2008.12.017
Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells.
Soo-Jin Choi (2009)
Pharma Research Library International Journal of Current Trends in Pharmaceutical Research
Tiara Anantha (2013)
10.1007/s11051-012-0964-8
Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications
Gozde Unsoy (2012)
10.1021/cr200359p
Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy.
Jun Yao (2014)
10.1021/la802405p
Pure insulin nanoparticle agglomerates for pulmonary delivery.
Mark M. Bailey (2008)
10.1016/j.bios.2013.09.012
Polymers effects on synthesis of AuNPs, and Au/Ag nanoalloys: indirectly generated AuNPs and versatile sensing applications including anti-leukemic agent.
Shanaz Jahan (2014)
10.1016/J.COLSURFA.2012.09.020
Amino covalent binding approach on iron oxide nanoparticle surface: Toward biological applications
Nébéwia Griffete (2012)
10.1002/jps.22091
Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.
Jasmine M. Tam (2010)
10.1002/med.20140
Nanoparticle formulations in pulmonary drug delivery.
Mark M. Bailey (2009)
10.1007/s10637-009-9253-5
Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent
Mi Kyung Kwak (2009)
10.1016/j.peptides.2010.10.003
Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation
Subhash Chandra Yadav (2011)
10.4172/2155-983X.1000137
Histology Study of Wistar Rats Implanted With and Without C6 Cells andthe Effect of NPt-Cu Nanoparticles
Tessy López (2015)
10.1002/wnan.1401
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
Young Hee Lim (2016)
Evaluation of the Droplet Collapsibility in Inhalation Drug Delivery through a 3D Computational Study
Matin N. Ashtiani (2012)
Lentiviral Vector-Mediated Gene Transfer and Applications in the Field of the Respiratory Epithelium
Stefano Castellani (2013)
10.1016/J.OPTMAT.2017.04.044
Terbium content affects the luminescence properties of ZrO2:Tb nanoparticles for mammary cancer imaging in mice
Jarosław Kaszewski (2017)
10.1016/J.SNB.2013.09.115
A nanoporous membrane based impedance sensing platform for DNA sensing with gold nanoparticle amplification
Wei Wei Ye (2014)
10.1007/s00018-013-1345-x
Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes
Nelson Gomes Oliveira Junior (2013)
10.1007/s40005-019-00443-1
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
Fakhrossadat Emami (2019)
10.1186/1479-0556-5-4
Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene
Xiaoyuan Kong (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar